The current institutional shareholding score of Artiva Biotherapeutics Inc is 5.00, ranking 133 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 68.82%, representing a quarter-over-quarter decrease of 16.15%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.32% of shares outstanding, with 94.29% increase in holdings.